Analysed CASTLE BIOSCIENCES INC (CSTL:NASDAQ) News Sources
New Decision Modeling Study Demonstrates TissueCypher® Significantly Improves Risk-Aligned Management for Patients with Barrett's Esophagus
15-09-2026
yahoo.com
New Study Highlights Clinical Need for Molecular Guidance in Atopic Dermatitis Treatment Selection, Reinforcing the Value of AdvanceAD-Tx™
24-09-2026
yahoo.com
New Study Shows That TissueCypher® Changed Management at an Expert Surgery Center in 90% of Patients With Non-Dysplastic Barrett's Esophagus
28-09-2026
yahoo.com
Late-Breaking EADV 2026 Data Support Use of DecisionDx®-Melanoma in SLNB Decision-Making and Risk-Aligned Post Surgical Management
30-09-2026
yahoo.com
New Melanoma Study Backing DecisionDx-Melanoma Could Be A Game Changer For Castle Biosciences (CSTL)
09-10-2026
yahoo.com
ACG 2026 Data Show TissueCypher® Identifies Elevated Risk of Progression Beyond Pathology Findings in Barrett's Esophagus
12-10-2026
yahoo.com
What is the current price of CASTLE BIOSCIENCES INC (CSTL:NASDAQ)?
The current price of CASTLE BIOSCIENCES INC (CSTL:NASDAQ) is $31.96.
CASTLE BIOSCIENCES INC (CSTL:NASDAQ) absolute price change since previous trading day?
The absolute price change of CASTLE BIOSCIENCES INC (CSTL:NASDAQ) since the previous trading day is $-1.84.
CASTLE BIOSCIENCES INC (CSTL:NASDAQ) percentage price change since previous trading day?
The percentage price change of CASTLE BIOSCIENCES INC (CSTL:NASDAQ) since the previous trading day is -5.4438%.
What is the most recent average sentiment score for CASTLE BIOSCIENCES INC (CSTL:NASDAQ)?
The most recent average sentiment score for CASTLE BIOSCIENCES INC (CSTL:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for CASTLE BIOSCIENCES INC (CSTL:NASDAQ)?
The most recent sentiment for CASTLE BIOSCIENCES INC (CSTL:NASDAQ) is .
SEC-8K** Filing Available For CASTLE BIOSCIENCES INC (CSTL:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.